Afya Stock Target Price and Analyst Consensus
| AFYA Stock | USD 18.27 0.09 0.50% |
The current analyst and expert consensus on Afya is Buy with 4 hold recommendations. The current projected Afya target price consensus is 21.47 with 7 analyst opinions. One of the most common ways Afya analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Afya vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Afya. We strongly encourage you to use your own analysis of Afya to validate this buy or sell advice. Afya recommendation module provides expert sentiment on the projected Afya target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Afya to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Afya Stock refer to our How to Trade Afya Stock guide.
Lowest Forecast 19.54 | Highest Forecast 23.83 | Target Price 21.47 |
Afya |
It's important to approach Afya's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Afya Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Afya target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Afya's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Buy |
Most Afya analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Afya stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Afya, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAfya Target Price Projection
Afya's current and average target prices are 18.27 and 21.47, respectively. The current price of Afya is the price at which Afya is currently trading. On the other hand, Afya's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Afya Target Price
Afya Analyst Ratings
Afya's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Afya stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Afya's financials, market performance, and future outlook by experienced professionals. Afya's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Afya price targets
Afya's stock target price is an estimate of its future price, usually made by analysts. Using Afya's target price to determine if it is a suitable investment can be done through the following steps:- Look at Afya's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Afya's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Afya Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Afya is a key component of Afya valuation and have some predictive power on the future returns of a Afya.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Afya's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Chemicals Invested over 30 shares | |
 | Hedge Favorites Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Warren Buffett Holdings Invested over 40 shares | |
 | Banking Invested over 30 shares | |
 | Business Services Invested few shares | |
Check out Macroaxis Advice on Afya to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Afya Stock refer to our How to Trade Afya Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Afya Stock analysis
When running Afya's price analysis, check to measure Afya's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Afya is operating at the current time. Most of Afya's value examination focuses on studying past and present price action to predict the probability of Afya's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Afya's price. Additionally, you may evaluate how the addition of Afya to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Correlations Find global opportunities by holding instruments from different markets |
The data published in Afya's official financial statements usually reflect Afya's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Afya. For example, before you start analyzing numbers published by Afya accountants, it's critical to develop an understanding of what Afya's liquidity, profitability, and earnings quality are in the context of the Diversified Consumer Services space in which it operates.
Please note, the presentation of Afya's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Afya's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Afya's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Afya. Please utilize our Beneish M Score to check the likelihood of Afya's management manipulating its earnings.